| Financial Year |
March 31 2023 |
| Monetary Funds |
162,099,121.13 |
| Held-for-trading Financial Assets |
197,911.31 |
| Notes Receivable |
81,696,151.85 |
| Accounts Receivable |
347,894,175.72 |
| Advances to Suppliers |
10,203,125.44 |
| Other Receivables |
10,254,074.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
524,654,185.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,618,163.81 |
| Total Current Assets |
1,160,781,914.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,009,877,552.70 |
| Under-construction Projects |
32,360,821.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,580,723.09 |
| R&D expenses |
20,506,137.16 |
| Goodwill |
215,394,375.13 |
| Long-Term Deferred and Prepaid Expenses |
648,567.25 |
| Deferred Income Tax Assets |
79,499,212.80 |
| Other Non-Current Assets |
10,246,970.88 |
| Sub-Total of Non-Current Assets |
1,476,985,377.59 |
| Total Assets |
2,637,767,291.86 |
| Short-Term Loans |
294,449,088.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,865,324.34 |
| Accounts Payable |
105,753,562.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,577,713.27 |
| Taxes Payable |
13,564,107.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
181,629,040.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
121,618,626.83 |
| Other Current Liabilities |
56,756,767.02 |
| Sub-Total of Current Liabilities |
849,901,763.73 |
| Long-term Loans |
314,774,529.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
75,595,368.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
23,623,972.85 |
| Deferred Income Tax Liabilities |
15,710,658.54 |
| Other Non-Current Liabilities |
54,220.58 |
| Sub-Total of Non-Current Liabilities |
495,723,208.06 |
| Total Liabilities |
1,345,624,971.79 |
| Paid-In Capital(Or Share Stock) |
306,072,836.00 |
| Capital Surplus |
533,804,981.77 |
| Surplus Reserve |
61,126,929.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
369,337,778.39 |
| Minority Stockholder's Interest |
1,295,014.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,290,847,305.08 |
| Owner's Equity（Stockholder's Equity） |
1,292,142,320.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,637,767,291.86 |
